This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Chronic postrheumatic arthropathy [Jaccoud]
M13_POSTRHEU
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
49 |
4. Check minimum number of eventsNone |
49 |
5. Include endpointsNone |
49 |
6. Filter based on genotype QC (FinnGen only) |
49 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M12
- Name in latin
- Arthropathia postrheumatica chronica (Jaccoud)
Similar endpoints
↥List of similar endpoints to
Chronic postrheumatic arthropathy [Jaccoud]
based on the number of shared cases.
Similar with more cases:
- Other specific arthropathies, wide
- Polyarthropathies
- Finngen Rheumatological endpoints
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 427 | 288 | 134 |
| Only index persons | 340 | 231 | 109 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 57.18 | 57.81 | 55.83 |
| Only index persons | 56.18 | 56.77 | 54.92 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 49 | 31 | 18 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 53.71 | 52.10 | 56.49 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
16
39
5.61
6.69
1.3
1.3
iu/ml
35.9
14.8
—
8
15
(42870588) Differential panel, method unspecified - Blood
21
98
3.00
3.33
7.7
3.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
15
4.40
2.11
1.5
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
18
96
2.38
2.05
2.9
3.0
mg/l
2818.9
800.5
0.30
12
56
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
8
27
3.33
2.04
5.4
2.8
—
59.6
—
0
10
(3020682) Albumin/Creatinine [Ratio] in Urine
18
106
2.10
1.57
4.1
4.0
mg/mmol
1.0
10.0
1.42
12
68
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
15
3.58
1.56
1.4
2.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
16
3.35
1.47
3.2
2.2
—
—
—
0
0
(4010399)
9
41
2.46
1.46
1.6
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
13
70
2.17
1.40
7.6
5.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
17
3.15
1.39
1.6
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
8
41
2.13
1.15
1.9
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
32
2.38
1.13
2.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
34
2.23
1.08
3.4
3.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
12
70
1.95
1.04
3.6
4.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
0
30
0.00
1.01
0.0
6.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
43
376
2.17
0.99
15.8
12.6
mg/l
19.3
24.8
0.51
35
282
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
42
2.08
0.94
1.5
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
8
43
2.03
0.93
4.4
6.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
21
151
1.68
0.93
4.0
6.9
inr
1.0
1.3
—
8
52
(3003694) ABO and Rh group [Type] in Blood
6
105
0.51
0.85
1.3
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
6
33
1.93
0.82
7.3
3.2
u/l
235.5
226.9
—
6
33
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
20
147
1.61
0.79
2.9
3.6
ng/l
18.2
60.1
—
10
107
(3000330) Specific gravity of Urine by Test strip
5
26
2.02
0.73
5.0
4.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
38
330
1.67
0.71
17.6
13.2
%
38.8
38.6
0.04
23
215
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
43
1.73
0.70
1.6
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
21
0.00
0.61
0.0
3.1
—
0.0
—
0
21
(3014007) Fractional oxyhemoglobin in Arterial blood
0
21
0.00
0.61
0.0
7.1
—
93.8
—
0
21
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
23
0.00
0.60
0.0
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9
59
1.64
0.59
1.7
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
31
266
1.45
0.54
6.4
4.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
22
178
1.43
0.52
4.6
5.2
mmol/l
1.2
1.2
0.66
22
164
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
20
159
1.44
0.52
4.0
3.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
19
151
1.42
0.49
2.7
1.9
pmol/l
96.8
91.7
0.16
12
74
(3007853) Bacteria identified in Skin by Aerobe culture
5
31
1.68
0.44
1.6
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
58
1.45
0.44
1.9
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.42
0.0
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
0
15
0.00
0.42
0.0
8.3
—
23.8
—
0
15
(3020891) Body temperature
0
16
0.00
0.42
0.0
3.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.3
—
305.6
—
0
9
(3013512) EKG study
14
108
1.41
0.41
4.7
4.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
12
91
1.42
0.38
10.3
5.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
43
401
1.59
0.37
15.8
12.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
11
83
1.42
0.36
3.6
2.7
e6/l
2.0
3.4
0.76
11
70
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
25
218
1.30
0.33
3.4
3.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
54
1.34
0.32
2.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
64
1.30
0.29
1.8
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
9
76
1.23
0.26
1.8
3.4
mmol/l
2.4
2.5
—
9
67
(3020564) Creatinine [Moles/volume] in Serum or Plasma
42
396
1.42
0.25
18.1
15.1
umol/l
77.3
76.6
0.06
42
396
(3023103) Potassium [Moles/volume] in Serum or Plasma
41
389
1.33
0.24
17.2
14.9
mmol/l
4.0
4.0
0.01
41
374
(3019550) Sodium [Moles/volume] in Serum or Plasma
41
391
1.30
0.24
16.8
14.8
mmol/l
139.9
139.9
0.02
41
377
(3002582) Erythrocytes [#/volume] in Urine
10
123
0.77
0.24
5.4
3.1
e6/l
11.3
61.1
—
10
87
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
17
146
1.25
0.23
3.8
4.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
42
1.21
0.22
4.2
3.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3036489) Thrombin time
0
10
0.00
0.21
0.0
1.2
—
20.9
—
0
10
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(1002224) Polysomnography panel
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
797.1
—
0
14
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
19
169
1.20
0.18
2.0
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
6
75
0.77
0.17
1.5
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
72
1.13
0.17
2.4
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
14
122
1.21
0.16
2.5
2.1
u/l
63.4
54.1
0.51
14
115
(1761868) Lipid panel - Serum or Plasma
14
123
1.19
0.14
2.6
3.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
11
95
1.20
0.13
4.2
3.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5
46
1.10
0.10
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
27
256
1.12
0.09
5.6
3.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
5
60
0.81
0.09
3.8
2.6
e6/l
0.7
1.5
—
5
30
(3007461) Platelets [#/volume] in Blood
43
421
1.17
0.08
23.6
18.4
e9/l
254.0
249.5
0.18
43
406
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
140
0.90
0.05
3.1
3.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
23
240
0.92
0.04
3.7
2.7
u/l
36.8
48.3
0.84
23
227
(36304419) Bacteria [Presence] in Urine
10
108
0.91
0.03
4.5
2.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
11
103
1.09
0.02
1.6
2.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
35
353
0.97
0.00
13.0
12.4
ml/min/173m2
76.6
79.2
0.35
35
295
(3041096) Erythrocytes [Presence] in Urine by Automated
11
114
0.95
0.00
3.7
3.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
32
322
0.98
0.00
19.0
16.1
%
13.8
13.7
0.36
32
311
(3030467) Casts [#/volume] in Urine by Automated count
11
112
0.98
0.00
5.1
2.9
e6/l
0.0
0.4
1.68
11
78
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
43
423
1.13
0.00
23.6
18.3
e9/l
7.4
6.7
0.88
43
409
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
43
422
1.15
0.00
23.5
18.3
fl
92.2
91.0
0.93
43
412
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.8
—
28.1
—
0
6
(3011985) Renin [Units/volume] in Plasma
0
7
0.00
0.00
0.0
1.0
—
25.7
—
0
7
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
1.0
—
13.0
—
0
6
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
7
0.00
0.00
0.0
1.7
—
64.3
—
0
7
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
0
7
0.00
0.00
0.0
1.9
—
25.1
—
0
7
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
43
422
1.15
0.00
23.8
18.4
g/l
132.6
132.9
0.05
43
411
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
7.7
—
26.7
—
0
6
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
6
0.00
0.00
0.0
1.2
—
79.5
—
0
6
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
6
0.00
0.00
0.0
2.3
—
29.8
—
0
6
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
43
422
1.15
0.00
23.5
18.2
pg
30.6
30.3
0.49
43
412
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
3.6
—
0
7
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
5
0.00
0.00
0.0
1.0
—
12.1
—
0
5
(3026361) Erythrocytes [#/volume] in Blood
43
422
1.15
0.00
23.6
18.3
e12/l
4.3
4.4
0.34
43
408
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.1
—
175.6
—
0
7
(3026008) Bacteria identified in Urine by Culture
12
120
1.00
0.00
6.4
3.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
35.9
—
0
5
(4281824)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.3
—
51.1
—
0
8
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_POSTRHEU and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_POSTRHEU | 1.159 [0.87, 1.54] | 0.311 |
| Birth year | 0.989 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 185 females with M13_POSTRHEU died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have M13_POSTRHEU.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.088% | No data |
| 5 | 0.514% | No data |
| 10 | 1.368% | No data |
| 15 | 2.583% | No data |
| 20 | 4.369% | No data |
Relationships between endpoints
↥Index endpoint: M13_POSTRHEU – Chronic postrheumatic arthropathy [Jaccoud]
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data